Wednesday, February 11, 2009

Breast Cancer News Digest 2/11/2009

Following are links to some of the latest news about breast cancer:

Cochrane Collaboration Releases Two New Reviews* of Breast Cancer Research

Post-operative radiotherapy for ductal carcinoma in situ of the breast (Radiation Benefits Women With Early Breast Cancer):

Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery:

* What is a systematic review?

Pregnancy Has No Impact on Breast Cancer Survival, Delays Treatment & Diagnosis

When Informed, All Women Do Not Prefer Breast Conservation

New Genomic Test Can Personalize Breast Cancer Treatment
"Unlike a widely used genomic test that applies only to lymph-node negative, estrogen-receptor positive breast cancer, this new genomic test is broadly applicable for all women diagnosed with breast cancer," says breast cancer specialist Matthew Ellis, M.D., Ph.D., a member of the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University.

"They found that luminal A was not sensitive to the chemotherapy, suggesting that patients with this good-prognosis type can forgo chemotherapy in favor of hormone-based therapy. They showed that among the poor-prognosis tumor types, basal-like breast cancer was the most sensitive to the chemotherapy and luminal B the least."

Editorial: Barriers to Delivery of Psychosocial Care for Cancer Patients

Predictors of Referral for Psychosocial Services: Recommendations From the Institute of Medicine Report—Cancer Care for the Whole Patient

Multivitamin Use and Risk of Cancer and Cardiovascular Disease in the Women's Health Initiative Cohorts

Pathway for cancer chemotherapy unveiled

No comments:

Post a Comment